EPHA2
protein-codingEPH receptor A2, the group of EPH receptors|Sterile alpha motif domain containing
Gene summary
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.[provided by RefSeq, May 2010]
- ECK
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~31.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0020378
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007288
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007288
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0020376
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007288
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0018610
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0021548
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011060
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0005328
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007288
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EPHA2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004431.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 62 | 16 | 88 | ||
| missense | 2 | 3 | 224 | 32 | 6 | 267 |
| nonsense | 2 | 2 | 1 | 5 | ||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 3 | 2 | 10 | ||
| splice donor/acceptor (+/-2bp) | 2 | 3 | 9 | 14 | ||
| Total | 11 | 12 | 246 | 94 | 22 | 385 |
Highest pathogenic variant AF is 0.000014910203
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004422.2 | 17 | MANE Select | |
| Ensembl | ENSP00000351209.5 | 17 | MANE Select | |
| RefSeq | NP_001316019.1 | 15 | Standard | |
| Ensembl | ENSP00000533652.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- Axon guidance - Homo sapiens (human)
- Rap1 signaling pathway - Homo sapiens (human)
- Ras signaling pathway - Homo sapiens (human)
- MAPK signaling pathway - Homo sapiens (human)
Biological Process
- skeletal system development
- vasculogenesis
- osteoblast differentiation
- blood vessel endothelial cell proliferation involved in sprouting angiogenesis
- inflammatory response
Molecular Function
- virus receptor activity
- transmembrane receptor protein tyrosine kinase activity
- transmembrane-ephrin receptor activity
- protein binding
- ATP binding
Cellular Component
- plasma membrane
- integral component of plasma membrane
- focal adhesion
- cell surface
- lamellipodium
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000358432
- Coding exons
- 17
- Length
- 31751
- Individuals with no LoFs
- 125695
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 53
- Defined
- 125748
- p
- 0.000211
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.56 | 508 | 617 | 0.824 | 0.0000442 | 6343 |
| Missense (PolyPhen) | 175 | 258.77 | 0.67627 | 2632 | ||
| Synonymous | -0.831 | 281 | 264 | 1.07 | 0.0000206 | 1945 |
| Loss of Function | 3.95 | 17 | 45.9 | 0.370 | 0.00000248 | 499 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00034 | 0.00032 | rare |
| European (Non-Finnish) | 0.00029 | 0.00029 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand- independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis. {ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:16236711, ECO:0000269|PubMed:18339848, ECO:0000269|PubMed:19573808, ECO:0000269|PubMed:20679435, ECO:0000269|PubMed:20861311, ECO:0000269|PubMed:23358419, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:27385333}.;
- Disease
- DISEASE: Cataract 6, multiple types (CTRCT6) [MIM:116600]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT6 includes posterior polar and age- related cortical cataracts, among others. Posterior polar cataract is a subcapsular opacity, usually disk-shaped, located at the back of the lens. Age-related cortical cataract is a developmental punctate opacity restricted to the cortex. The cataract is white or cerulean, increases in number with age, but rarely affects vision. {ECO:0000269|PubMed:19005574, ECO:0000269|PubMed:19306328, ECO:0000269|PubMed:19649315, ECO:0000269|PubMed:22570727}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Overexpressed in several cancer types and promotes malignancy. {ECO:0000269|PubMed:19573808}.;
Recessive Scores
- pRec
- 0.289
Intolerance Scores
- LoFtool
- 0.473
- RVIS EVS
- -0.63
- RVIS percentile EVS
- 16.82
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.757
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |